The suit alleges that Purdue did not accurately represent the addictive qualities of OxyContin in their marketing campaigns and overstated the benefits of using opioids to treat chronic pain. It is still unknown what kinds of damages New Hampshire is seeking.
“We share New Hampshire officials’ concerns about the opioid crisis and we are committed to working collaboratively to find solutions,” Purdue said in a statement, though they denied any wrongdoing.
More Articles on Opioids:
Opioid overdose deaths could be higher than CDC numbers indicate, study finds
Physicians from lower-tier med schools prescribe more opioids
Insys Therapeutics may settle Illinois opioid lawsuit for up to $4.5M: 5 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
